WOOD Pharma Holding, which bought a pharmaceutical production plant in Hlohovec from Sanofi subsidiary Zentiva last year, acquired with it two trademarks: Indulona, a hand-cream; and Parexyl, a toothpaste.
It failed to obtain from Zentiva the rights to use the name Slovakofarma, by which the Hlohovec plant, whose history of pharmaceutical production dates back 70 years, used to be known.
“Only experiences with them [Indulona and Parexyl] will show whether we will continue with their production,” said Ľubomír Šoltýs, co-owner of Wood Pharma Holding, an investment group, as quoted by the Trend weekly.
In early January the firm announced investments in new equipment, the development of new products and the removal of historical environmental burdens, the SITA newswire reported.
4. Feb 2013 at 0:00 | Compiled by Spectator staff